In an article for the Financial Times, Laura Noonan highlights Prof. Andrew Lo’s work investigating how the theories of financial engineering could be used to fight cancer. “In cancer drug development, because the risks of failure are so high, the probability of success goes up quite dramatically if you create a portfolio,” says Lo.